Crossmark

Development of cyclodextrin-based extract of Lotus corniculatus as a potential substrate reduction therapy in mucopolysaccharidoses type III

Published Online: 2018-11-02

Published Print: 2018-12

Authors

Fumić, Barbara https://orcid.org/0000-0003-0396-8976
Končić, Marijana Zovko https://orcid.org/0000-0002-8787-6667
Jug, Mario https://orcid.org/0000-0002-7473-9807
Funding

Funding for this research was provided by:

University of Zagreb (BM1.10)
License Information

Text and Data Mining valid from 2018-11-02
More Information

Article History

Received: 31 July 2018

Accepted: 29 October 2018

First Online: 2 November 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: The research was performed in accordance with ethical committee approval (Class: 643-03/l4-QL/04; No. 251-62-03-L4-33; Zagreb, 16 May 2014).

Document is current